142 related articles for article (PubMed ID: 34481855)
1. Phytochemical thymoquinone prevents hemoglobin glycoxidation and protofibrils formation: A biophysical aspect.
Ishtikhar M; Siddiqui Z; Ahmad A; Ashraf JM; Arshad M; Doctor N; Al-Kheraif AA; Zamzami MA; Al-Thawadi SM; Kim J; Khan RH
Int J Biol Macromol; 2021 Nov; 190():508-519. PubMed ID: 34481855
[TBL] [Abstract][Full Text] [Related]
2. d-Ribose induced glycoxidative insult to hemoglobin protein: An approach to spot its structural perturbations.
Siddiqui Z; Ishtikhar M; Moinuddin ; Ahmad S
Int J Biol Macromol; 2018 Jun; 112():134-147. PubMed ID: 29378270
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of thymoquinone on glycation of human myoglobin induced by d-ribose.
Liu JJ; Wang ZY; Jiang BB; Gao SQ; Lin YW
Int J Biol Macromol; 2023 Dec; 253(Pt 4):127016. PubMed ID: 37741485
[TBL] [Abstract][Full Text] [Related]
4. A structural study on the protection of glycation of superoxide dismutase by thymoquinone.
Anwar S; Khan MA; Sadaf A; Younus H
Int J Biol Macromol; 2014 Aug; 69():476-81. PubMed ID: 24933520
[TBL] [Abstract][Full Text] [Related]
5. ADP-ribose in glycation and glycoxidation reactions.
Jacobson EL; Cervantes-Laurean D; Jacobson MK
Adv Exp Med Biol; 1997; 419():371-9. PubMed ID: 9193679
[TBL] [Abstract][Full Text] [Related]
6. Aspartic acid functions as carbonyl trapper to inhibit the formation of advanced glycation end products by chemical chaperone activity.
Prasanna G; Saraswathi NT
J Biomol Struct Dyn; 2016 May; 34(5):943-51. PubMed ID: 26325019
[TBL] [Abstract][Full Text] [Related]
7. Glycation, oxidation and glycoxidation of IgG: a biophysical, biochemical, immunological and hematological study.
Islam S; Moinuddin ; Mir AR; Raghav A; Habib S; Alam K; Ali A
J Biomol Struct Dyn; 2018 Aug; 36(10):2637-2653. PubMed ID: 28793850
[TBL] [Abstract][Full Text] [Related]
8. Characterizing harmful advanced glycation end-products (AGEs) and ribosylated aggregates of yellow mustard seed phytocystatin: Effects of different monosaccharides.
Ahmed A; Shamsi A; Bano B
Spectrochim Acta A Mol Biomol Spectrosc; 2017 Jan; 171():183-192. PubMed ID: 27526342
[TBL] [Abstract][Full Text] [Related]
9. Non enzymatic covalent modification by glycolysis end product converts hemoglobin into its oxidative stress potency state.
Esackimuthu P; Saraswathi NT
Biochem Biophys Res Commun; 2021 Jan; 534():387-394. PubMed ID: 33261885
[TBL] [Abstract][Full Text] [Related]
10. Molten globule of hemoglobin proceeds into aggregates and advanced glycated end products.
Iram A; Alam T; Khan JM; Khan TA; Khan RH; Naeem A
PLoS One; 2013; 8(8):e72075. PubMed ID: 23991043
[TBL] [Abstract][Full Text] [Related]
11. A biochemical & biophysical study on in-vitro anti-glycating potential of iridin against d-Ribose modified BSA.
Nabi R; Alvi SS; Shah MS; Ahmad S; Faisal M; Alatar AA; Khan MS
Arch Biochem Biophys; 2020 Jun; 686():108373. PubMed ID: 32325089
[TBL] [Abstract][Full Text] [Related]
12. Monitoring the protective ability of thymoquinone mixture with p-cymene against bovine serum albumin (BSA) glycation: MCR-ALS analysis based on combined spectroscopic and electrochemical methods.
Benvidi A; Rezaeinasab M; Gharaghani S; Abbasi S
Int J Biol Macromol; 2018 Feb; 107(Pt B):2465-2474. PubMed ID: 29074084
[TBL] [Abstract][Full Text] [Related]
13. Anti-aggregation property of thymoquinone induced by copper-nanoparticles: A biophysical approach.
Ishtikhar M; Rahisuddin ; Khan MV; Khan RH
Int J Biol Macromol; 2016 Dec; 93(Pt A):1174-1182. PubMed ID: 27693336
[TBL] [Abstract][Full Text] [Related]
14. Nitroxides prevent protein glycoxidation in vitro.
Sadowska-Bartosz I; Galiniak S; Skolimowski J; Stefaniuk I; Bartosz G
Free Radic Res; 2015 Feb; 49(2):113-21. PubMed ID: 25363554
[TBL] [Abstract][Full Text] [Related]
15. Hydroxy methoxy benzaldehyde from Sesbania grandilfora inhibits the advanced glycation end products (AGEs)-mediated fibrillation in hemoglobin.
Prasanna G; Hari N; Saraswathi NT
J Biomol Struct Dyn; 2018 Mar; 36(4):819-829. PubMed ID: 28317461
[TBL] [Abstract][Full Text] [Related]
16. Protective actions of bioactive flavonoids chrysin and luteolin on the glyoxal induced formation of advanced glycation end products and aggregation of human serum albumin: In vitro and molecular docking analysis.
Sarmah S; Das S; Roy AS
Int J Biol Macromol; 2020 Dec; 165(Pt B):2275-2285. PubMed ID: 33058977
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of glycoxidation of bovine serum albumin by glucose, fructose and ribose and its prevention by food components.
Sadowska-Bartosz I; Galiniak S; Bartosz G
Molecules; 2014 Nov; 19(11):18828-49. PubMed ID: 25407721
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of auto-antibodies against D-ribose-glycated-hemoglobin in diabetes mellitus.
Siddiqui Z; Faisal M; Alatar AR; Ahmad S
Glycobiology; 2019 May; 29(5):409-418. PubMed ID: 30834437
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the antiglycating potential of thymoquinone and its interaction with BSA.
Kumar D; Desa A; Chougle S; Bhatkalkar SG; Sachar S; Selvaa Kumar C; Ali A
J Biomol Struct Dyn; 2022 Nov; 40(18):8455-8463. PubMed ID: 33908315
[TBL] [Abstract][Full Text] [Related]
20. Effect of Glyoxal Modification on a Critical Arginine Residue (Arg-31α) of Hemoglobin: Physiological Implications of Advanced Glycated end Product an
Banerjee S
Protein Pept Lett; 2020; 27(8):770-781. PubMed ID: 31774041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
